Literature DB >> 11892069

Wiskott-Aldrich syndrome.

S Nonoyama1, H D Ochs.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency characterized by thrombocytopenia with small platelets, eczema, recurrent infections, autoimmune disorders, IgA nephropathy, and an increased incidence of hematopoietic malignancies. The identification of the responsible gene, WASP (Wiskott-Aldrich Syndrome Protein), revealed clinical heterogeneity of the syndrome, and showed that X-linked thrombocytopenia without, or with only mild immunodeficiency and eczema, is also caused by mutations of WASP. The study of WASP and its mutations demonstrates how a single gene defect can cause multiple and complex clinical symptoms.

Entities:  

Mesh:

Year:  2001        PMID: 11892069     DOI: 10.1007/s11882-001-0028-0

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  65 in total

Review 1.  Signalling to actin: the Cdc42-N-WASP-Arp2/3 connection.

Authors:  M F Carlier; A Ducruix; D Pantaloni
Journal:  Chem Biol       Date:  1999-09

2.  The identification and characterization of two promoters and the complete genomic sequence for the Wiskott-Aldrich syndrome gene.

Authors:  T L Hagemann; S P Kwan
Journal:  Biochem Biophys Res Commun       Date:  1999-03-05       Impact factor: 3.575

3.  Two tandem verprolin homology domains are necessary for a strong activation of Arp2/3 complex-induced actin polymerization and induction of microspike formation by N-WASP.

Authors:  H Yamaguchi; H Miki; S Suetsugu; L Ma; M W Kirschner; T Takenawa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

4.  The thrombocytopenia of Wiskott Aldrich syndrome is not related to a defect in proplatelet formation.

Authors:  E Haddad; E Cramer; C Rivière; P Rameau; F Louache; J Guichard; D L Nelson; A Fischer; W Vainchenker; N Debili
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

Review 5.  Thrombocytopenia: mechanisms and management of defects in platelet production.

Authors:  S J Slichter; L A Harker
Journal:  Clin Haematol       Date:  1978-10

6.  Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation.

Authors:  M D Gallego; M Santamaría; J Peña; I J Molina
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

7.  Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells.

Authors:  R Rengan; H D Ochs; L I Sweet; M L Keil; W T Gunning; N A Lachant; L A Boxer; G M Omann
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

8.  WIP, a protein associated with wiskott-aldrich syndrome protein, induces actin polymerization and redistribution in lymphoid cells.

Authors:  N Ramesh; I M Antón; J H Hartwig; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

9.  Intrinsic dendritic cell abnormalities in Wiskott-Aldrich syndrome.

Authors:  M Binks; G E Jones; P M Brickell; C Kinnon; D R Katz; A J Thrasher
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

10.  Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.

Authors:  J Zhang; A Shehabeldin; L A da Cruz; J Butler; A K Somani; M McGavin; I Kozieradzki; A O dos Santos; A Nagy; S Grinstein; J M Penninger; K A Siminovitch
Journal:  J Exp Med       Date:  1999-11-01       Impact factor: 14.307

View more
  1 in total

1.  Requirement for a complex of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein in podosome formation in macrophages.

Authors:  Shigeru Tsuboi
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.